{"filing":{"accession_number":"0001140361-26-022984","cik":"0001671927","ticker":"IMCR","company_name":"Immunocore Holdings plc","form":"8-K","filing_date":"2026-05-27","report_date":null,"primary_document":"ef20075013_form8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1671927/000114036126022984/ef20075013_form8k.htm"},"events":[{"id":8695,"run_id":7634,"accession_number":"0001140361-26-022984","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a clear disclosure of shareholder vote results from Immunocore's 2026 Annual General Meeting held on May 27, 2026. The filing presents the voting outcomes for ten resolutions, including director re-appointments, executive compensation approval, auditor ratification, and financial statement adoption—all standard AGM matters. Item 5.07 explicitly requires disclosure of shareholder meeting results, and the detailed vote tallies (for, against, abstain) for each resolution are the core content of this 8-K section.","company_name":"Immunocore Holdings plc","ticker":"IMCR","filing_date":"2026-05-27","form":"8-K","submitted_at":null,"items":[{"id":1855,"accession_number":"0001140361-26-022984","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from Immunocore's 2026 Annual General Meeting held on May 27, 2026. The filing presents the voting outcomes for ten resolutions, including director re-appointments, executive compensation approval, auditor ratification, and financial statement adoption—all standard AGM matters. Item 5.07 explicitly requires disclosure of shareholder meeting results, and the detailed vote tallies (for, against, abstain) for each resolution are the core content of this 8-K section.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-28T02:11:29.814742+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":1855,"accession_number":"0001140361-26-022984","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from Immunocore's 2026 Annual General Meeting held on May 27, 2026. The filing presents the voting outcomes for ten resolutions, including director re-appointments, executive compensation approval, auditor ratification, and financial statement adoption—all standard AGM matters. Item 5.07 explicitly requires disclosure of shareholder meeting results, and the detailed vote tallies (for, against, abstain) for each resolution are the core content of this 8-K section.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-28T02:11:29.814742+00:00","company_name":"Immunocore Holdings plc","ticker":"IMCR","filing_date":"2026-05-27"}]}